Sonoma Pharmaceuticals, Inc. Stock Agreements

12 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
OCULUS INNOVATIVE SCIENCES, INC. Common Stock (par value $0.0001 per share) At-the-Market Issuance Sales Agreement
Stock Agreements
Sonoma Pharmaceuticals, Inc.
Pharmaceuticals
NY
2014
SONOMA PHARMACEUTICALS, INC. NON-EMPLOYEE DIRECTOR COMPENSATION PROGRAM AND STOCK OWNERSHIP GUIDELINES Revised by the Board of Directors on December29, 2022
Stock Agreements
Sonoma Pharmaceuticals, Inc.
Pharmaceuticals
2022
Specimen Common Stock Certificate
Stock Agreements
Sonoma Pharmaceuticals, Inc.
Pharmaceuticals
2017
OCULUS INNOVATIVE SCIENCES, INC. CERTIFICATE OF DESIGNATIONOF PREFERENCES, RIGHTS AND LIMITATIONS OF SERIES A 0% CONVERTIBLEPREFERRED STOCK PURSUANT TO SECTION 151OF THE DELAWARE...
Stock Agreements
Sonoma Pharmaceuticals, Inc.
Pharmaceuticals
NY
2012
WARRANTTO PURCHASE SHARES OFCOMMON STOCK OF OCULUSINNOVATIVE SCIENCES, INC. (Voidafter November 30, 2017) _______________________________________________
Stock Agreements
Sonoma Pharmaceuticals, Inc.
Pharmaceuticals
CA
2010
Common stock outstanding as of July 17, 2009
Stock Agreements
Sonoma Pharmaceuticals, Inc.
Pharmaceuticals
2009
Common stock outstanding as of July 17, 2009
Stock Agreements
Sonoma Pharmaceuticals, Inc.
Pharmaceuticals
2009
Common stock outstanding as of June 15, 2009
Stock Agreements
Sonoma Pharmaceuticals, Inc.
Pharmaceuticals
2009
Common stock outstanding as of June 15, 2009
Stock Agreements
Sonoma Pharmaceuticals, Inc.
Pharmaceuticals
2009
Common stock outstanding as of June 15, 2009
Stock Agreements
Sonoma Pharmaceuticals, Inc.
Pharmaceuticals
DE
2009
Common stock outstanding as of April 2, 2009
Stock Agreements
Sonoma Pharmaceuticals, Inc.
Pharmaceuticals
2009
One hundred shares of our common stock, par value $0.0001 per share
Stock Agreements
Sonoma Pharmaceuticals, Inc.
Pharmaceuticals
CA
2009